drug
pramipexole dihydrochloride ER
Marketedupdated 2mo agoby Boehringer Ingelheim Corp
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying pramipexole dihydrochloride ER
- phase1Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects
- phase3Phase III Long-Term Extension Study With Dexpramipexole
- phase3A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
- phase3A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
- phase3A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
- phase2A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 56m ago
Found something off?
comments(0)
5-min edit window · permanent after that